Literature DB >> 26549513

Daptomycin antibiotic lock therapy for hemodialysis patients with Gram-positive bloodstream infections following use of tunneled, cuffed hemodialysis catheters: retrospective single center analysis.

Hung-Wen Yen1,2, Wu-Chang Yang1,2, Der-Cherng Tarng1,2, Chih-Yu Yang1,2, Chiao-Lin Chuang3,2, Ling-Ju Huang3,4,2, Pei-Yu Lin5,2, Chih-Chun Wang1,2, Szu-Yuan Li1,2.   

Abstract

Catheter-related blood stream infection (CRBSI) is a major complication in hemodialysis patients. We assessed the efficacy of systemic daptomycin (DPT) plus DPT antibiotic lock therapy (DPT-ALT) for catheter salvage in patients with Gram-positive CRBSIs. This is a retrospective study of hemodialysis patients with tunneled and cuffed hemodialysis catheters. All patients were from a single institution in Taipei and received systemic DPT plus DPT-ALT for the treatment of Gram-positive CRBSI. Successful resolution of CRBSI was implemented. Resolution of fever within 48 hours, negative result of repeated blood cultures after resolution of fever, no clinical evidence of CRBSI relapse and no need for catheter removal were measured. Fifteen hemodialysis patients received DPT-ALT for CRBSI, nine with coagulase-negative Staphylococcus (CONS), two with methicillin-resistant Staphylococcus aureus (MRSA), three with methicillin-sensitive Staphylococcus aureus (MSSA) and one with polymicrobial infections. Systemic DPT plus DPT-ALT cured 11 patients (73.3%). Treatment failed in all three MRSA cases (two with MRSA and one with MRSA + Enterococcus faecalis). Retrospective design and small sample size were the limitations of this study. Systemic DPT plus DPT-ALT appears to be a promising treatment for CRBSI from CONS and MSSA, but not for MRSA CRBSI. Systemic DPT plus DPT-ALT should be considered for patients with CRBSIs caused by certain species.
© 2015 International Society for Hemodialysis.

Entities:  

Keywords:  Daptomycin; Gram-positive catheter-related bloodstream infections; Staphylococcus aureus; antibiotic lock therapy; cuffed hemodialysis catheter; tunneled

Mesh:

Substances:

Year:  2015        PMID: 26549513     DOI: 10.1111/hdi.12378

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  3 in total

1.  In Vitro Study To Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution.

Authors:  Marta Rubia; Andrea Cordero; María Jesús Pérez-Granda; Emilia Cercenado; Cristina Pascual; Patricia Muñoz; María Guembe
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

2.  Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants.

Authors:  Hong Liang; Lian Zhang; Xiaoping Guo; Li Sun
Journal:  BMC Pediatr       Date:  2021-01-04       Impact factor: 2.125

3.  A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing.

Authors:  Marta Díaz-Navarro; Rama Hafian; Irene Manzano; María J Pérez-Granda; Emilia Cercenado; Cristina Pascual; Carmen Rodríguez; Patricia Muñoz; María Guembe
Journal:  Infect Dis Ther       Date:  2022-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.